President Biden, citing the need for maximum flexibility in the nation’s vaccination program, today announced a deal for the U.S. government to purchase an additional 100 million doses of Johnson & Johnson’s single-shot COVID-19 vaccine.

Johnson & Johnson is working with Merck to increase supply, making such a deal possible.

The purchase doubles the nation’s projected supply of Johnson & Johnson doses, to 200 million. The intent of the purchase is to prepare for long-term supply needs, including the eventual vaccination of children and the possible need for booster shots to protect against COVID-19 variants.

Related News Articles

Headline
The Food and Drug Administration Friday authorized administering bamlanivimab and etesivimab together to treat or prevent COVID-19 in all pediatric…
Blog
To help hospitals and health system leaders stay up-to-date on all of the legal developments related to vaccine mandates, the AHA has developed a blog authored…
Perspective
With the calendar turning to December, Congress finds itself in a familiar position: a long to-do-list, impending deadlines and facing uncertainty over how…
Headline
The House this week passed the Maternal Vaccination Act (H.R. 951), an AHA-supported provision from the Black Maternal Health Momnibus Act that would…
Headline
The Centers for Medicare & Medicaid Services will not enforce its COVID-19 vaccine mandate for health care workers while enjoined by district courts in…
Headline
The Centers for Medicare & Medicaid Services today began requiring state Medicaid programs to cover counseling visits at which health care providers…